Back to search

Article

A Novel Digital PCR Assay for Accurate Detection and Differentiation of Focal and Non-Focal Subtypes of <i>MET</i> Amplification in Lung Cancer

2025-01-27

Abstract excerpt

Mesenchymal–epithelial transition (MET) gene amplification is a critical biomarker in non-small cell lung cancer (NSCLC), significantly influencing treatment decisions and prognostic evaluations. However, current detection methods such as fluorescence in situ hybridization (FISH) and next-generation sequencing (NGS) have limitations in speed, cost, and specificity, particularly when distinguishing between focal ME...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d99f35b2-d307-5c18-a121-1f5d86dd35ff
DOI
10.20944/preprints202501.1965.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A Novel Digital PCR Assay for Accurate Detection and Differentiation of Focal and Non-Focal Subtypes of <i>MET</i> Amplification in Lung CancerDOI 10.20944/preprints202501.1965.v1
Unraveling the Significance of MET Focal Amplification in Lung Cancer: Integrative NGS, FISH, and IHC Investigation.Semantic proximity
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsSemantic proximity
Bioinformatically Expanded Next-Generation Sequencing Analysis Optimizes Identification of Therapeutically Relevant MET Copy Number Alterations in >50,000 TumorsSemantic proximity
Detection of MET amplification by droplet digital PCR in peripheral blood samples of non-small cell lung cancer.Semantic proximity
Refining patient selection of MET-activated non-small cell lung cancer through biomarker precision.Semantic proximity
Optimized NGS-based de novo MET amplification detection for improved lung cancer patient managementSemantic proximity
Overview of Molecular Detection Technologies for MET in Lung CancerSemantic proximity
Comparison of in situ and extraction-based methods for the detection of MET amplifications in solid tumorsSemantic proximity
MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World SettingSemantic proximity
A rapid, multiplex digital PCR assay for <i>EGFR</i> , <i>KRAS</i> , <i>BRAF</i> , <i>ERBB2</i> variants and <i>ALK</i> , <i>RET</i> , <i>ROS1</i> , <i>NTRK1</i> gene fusions in non-small cell lung cancerSemantic proximity
A rapid, multiplex digital PCR assay to detect gene variants and fusions in non-small cell lung cancer.Semantic proximity
NGS and FISH for MET amplification detection in EGFR TKI resistant non-small cell lung cancer (NSCLC) patients: A prospective, multicenter study in ChinaSemantic proximity
Select a neighboring publication to make it the new centre.